- · Started to apply the disease marker analysis technology, which is a proprietary technology owned by GlycoMetrix in the US.
- · Based on the proprietary technology, established a fast and accurate early cancer diagnosis system and DB Signature for the first time in the world
- · Early diagnosis system for various cancers including ovarian cancer, breast cancer, and pancreatic cancer
- · Currently researching and developing early diagnosis techniques for major degenerative brain diseases (e.g. Parkinson’s disease, and Alzheimer’s)
Economical diagnostic system for accurate and rapid diagnosis and prevention of rare incurable diseases such as cancer and degenerative brain diseases